 Kintara Therapeutics NASDAQ:KTRA Inc presented data at the 2022 American Association for Cancer Research AACR Annual Meeting. The San Diego, California-based company is developing novel cancer therapies for patients with unmet medical needs, including VAL-083 for Glioblastoma Multiforme GBM and REM-001 for Cutaneous Metastatic Breast Cancer CMBC. 